Provided by Tiger Fintech (Singapore) Pte. Ltd.

Artiva Biotherapeutics, Inc.

2.10
+0.14007.14%
Post-market: 2.100.00000.00%18:45 EDT
Volume:212.21K
Turnover:443.85K
Market Cap:51.16M
PE:-0.50
High:2.14
Open:1.98
Low:1.96
Close:1.96
Loading ...
May 08, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2025

Major Issues Report

Form 8-K - Current report
Mar 24, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 24, 2025

Major Issues Report

Form 8-K - Current report
Jan 29, 2025

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2024

Major Issues Report

Form 8-K - Current report
Oct 22, 2024

Major Issues Report

Form 8-K - Current report
Sep 03, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Aug 29, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 29, 2024

Major Issues Report

Form 8-K - Current report
Aug 01, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Aug 01, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Aug 01, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Jul 29, 2024

Beneficial Ownership Change

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Jul 29, 2024

Beneficial Ownership Change

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Jul 22, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jul 22, 2024

Major Issues Report

Form 8-K - Current report
Jul 17, 2024

Correspondence

Form CORRESP - Correspondence